ULB Neuroscience Institute (UNI), Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Laboratory of Neuroscience, UMONS Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.
Pain. 2022 Aug 1;163(8):e927-e941. doi: 10.1097/j.pain.0000000000002536. Epub 2021 Dec 24.
Prdm12 is a conserved epigenetic transcriptional regulator that displays restricted expression in nociceptors of the developing peripheral nervous system. In mice, Prdm12 is required for the development of the entire nociceptive lineage. In humans, PRDM12 mutations cause congenital insensitivity to pain, likely because of the loss of nociceptors. Prdm12 expression is maintained in mature nociceptors suggesting a yet-to-be explored functional role in adults. Using Prdm12 inducible conditional knockout mouse models, we report that in adult nociceptors Prdm12 is no longer required for cell survival but continues to play a role in the transcriptional control of a network of genes, many of them encoding ion channels and receptors. We found that disruption of Prdm12 alters the excitability of dorsal root ganglion neurons in culture. Phenotypically, we observed that mice lacking Prdm12 exhibit normal responses to thermal and mechanical nociceptive stimuli but a reduced response to capsaicin and hypersensitivity to formalin-induced inflammatory pain. Together, our data indicate that Prdm12 regulates pain-related behavior in a complex way by modulating gene expression in adult nociceptors and controlling their excitability. The results encourage further studies to assess the potential of Prdm12 as a target for analgesic development.
PRDM12 是一种保守的表观遗传转录调节剂,在发育中的周围神经系统感觉神经元中表达受限。在小鼠中,PRDM12 对于整个伤害感受谱系的发育是必需的。在人类中,PRDM12 突变导致先天性痛觉缺失,可能是由于伤害感受器的丧失。PRDM12 的表达在成熟的伤害感受器中得到维持,这表明其在成人中具有尚未探索的功能作用。我们使用 Prdm12 诱导的条件性基因敲除小鼠模型,报告称在成年伤害感受器中,Prdm12 不再需要细胞存活,但继续在基因网络的转录控制中发挥作用,其中许多基因编码离子通道和受体。我们发现 Prdm12 的破坏会改变培养中的背根神经节神经元的兴奋性。表型上,我们观察到缺乏 Prdm12 的小鼠对热和机械伤害感受刺激的反应正常,但对辣椒素的反应降低,对福尔马林诱导的炎症性疼痛过敏。总之,我们的数据表明,Prdm12 通过调节成年伤害感受器中的基因表达并控制其兴奋性,以复杂的方式调节与疼痛相关的行为。这些结果鼓励进一步研究评估 Prdm12 作为镇痛药物开发靶点的潜力。